BioLife Solutions Statistics
Total Valuation
BLFS has a market cap or net worth of $968.37 million. The enterprise value is $964.02 million.
| Market Cap | 968.37M |
| Enterprise Value | 964.02M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BLFS has 46.07 million shares outstanding. The number of shares has increased by 5.59% in one year.
| Shares Outstanding | 46.07M |
| Shares Change (YoY) | +5.59% |
| Shares Change (QoQ) | +1.34% |
| Owned by Insiders (%) | 2.96% |
| Owned by Institutions (%) | 98.93% |
| Float | 35.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 250.00 |
| PS Ratio | 7.05 |
| Forward PS | 8.35 |
| PB Ratio | 2.90 |
| P/FCF Ratio | n/a |
| PEG Ratio | 65.38 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.89 |
| Quick Ratio | 1.65 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -37.98 |
Financial Efficiency
Return on equity (ROE) is -18.60% and return on invested capital (ROIC) is -18.77%.
| Return on Equity (ROE) | -18.60% |
| Return on Assets (ROA) | -15.20% |
| Return on Capital (ROIC) | -18.77% |
| Revenue Per Employee | $331,633 |
| Profits Per Employee | -$152,014 |
| Employee Count | 414 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 2.17 |
Taxes
In the past 12 months, BLFS has paid $208,000 in taxes.
| Income Tax | 208,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.91% in the last 52 weeks. The beta is 1.85, so BLFS's price volatility has been higher than the market average.
| Beta (5Y) | 1.85 |
| 52-Week Price Change | +3.91% |
| 50-Day Moving Average | 20.99 |
| 200-Day Moving Average | 16.85 |
| Relative Strength Index (RSI) | 50.88 |
| Average Volume (20 Days) | 365,940 |
Short Selling Information
The latest short interest is 4.15 million, so 9.01% of the outstanding shares have been sold short.
| Short Interest | 4.15M |
| Short Previous Month | 4.18M |
| Short % of Shares Out | 9.01% |
| Short % of Float | 11.54% |
| Short Ratio (days to cover) | 12.67 |
Income Statement
In the last 12 months, BLFS had revenue of $137.30 million and -$62.93 million in losses. Loss per share was -$1.42.
| Revenue | 137.30M |
| Gross Profit | 45.27M |
| Operating Income | -70.26M |
| Pretax Income | -62.73M |
| Net Income | -62.93M |
| EBITDA | -49.74M |
| EBIT | -61.12M |
| Loss Per Share | -$1.42 |
Balance Sheet
The company has $45.30 million in cash and $40.96 million in debt, giving a net cash position of $4.34 million or $0.09 per share.
| Cash & Cash Equivalents | 45.30M |
| Total Debt | 40.96M |
| Net Cash | 4.34M |
| Net Cash Per Share | $0.09 |
| Equity (Book Value) | 333.41M |
| Book Value Per Share | 7.24 |
| Working Capital | 73.04M |
Cash Flow
In the last 12 months, operating cash flow was -$14.26 million and capital expenditures -$7.76 million, giving a free cash flow of -$22.02 million.
| Operating Cash Flow | -14.26M |
| Capital Expenditures | -7.76M |
| Free Cash Flow | -22.02M |
| FCF Per Share | -$0.49 |
Margins
Gross margin is 32.97%, with operating and profit margins of -51.17% and -45.84%.
| Gross Margin | 32.97% |
| Operating Margin | -51.17% |
| Pretax Margin | -45.69% |
| Profit Margin | -45.84% |
| EBITDA Margin | -36.23% |
| EBIT Margin | -44.51% |
| FCF Margin | -16.04% |
Dividends & Yields
BLFS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.59% |
| Shareholder Yield | -5.59% |
| Earnings Yield | -6.50% |
| FCF Yield | -2.27% |
Analyst Forecast
The average price target for BLFS is $24.33, which is 15.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.33 |
| Price Target Difference | 15.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 14.49% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 29, 2014. It was a reverse split with a ratio of 1:14.
| Last Split Date | Jan 29, 2014 |
| Split Type | Reverse |
| Split Ratio | 1:14 |
Scores
BLFS has an Altman Z-Score of 7.44 and a Piotroski F-Score of 3.
| Altman Z-Score | 7.44 |
| Piotroski F-Score | 3 |